Mr. Schmidt is an executive and entrepreneur with more than 25 years of international experience in the Healthcare, Diagnostics, Life Science and Digital Health industries. Between 1998 and 2008 he was at Roche Diagnostics where he held various global senior leadership roles in Diabetes Care, Laboratory- and PoC-Diagnostics. From 2008 to 2011 he worked as an executive and CEO at Straumann Institute/Switzerland, responsible for the world-wide “Digitalization” of the dental industry.
Mr. Schmidt is currently active as an Independent Healthcare Professional providing board engagement as Chairman and NED in public and private MedTech and Life Science companies; consulting to top management teams to improve innovation, commercialization and digitalization processes; and consulting investors (Private Equity/Venture Capital) on identification of new investment and acquisition targets in the global healthcare industries.
He has a dual German and Swiss citizenship and he has held positions in Germany, Netherlands, USA, Canada, UK, Sweden, France, Ireland and Switzerland. Currently Mr. Schmidt serves among others as Chairman on the Board of Directors of Oncimmune plc, UK (Early Cancer Detection); Perfood GmbH, Germany (Digital Therapeutics).
I have worked with Dr. Kal Patel and his team since the inception of BrightInsight. I believe in their vision and have been impressed by their ability to execute on their strategy to enable biopharma and medtech companies to build, scale and maintain regulated digital health products. I am most excited to continue collaborating with the BrightInsight team to expand its global leadership position.
Switzerland (where I live), but I also love to travel to many other places!